Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Diabetes
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Diabetes
    TopAbstracts in Diabetes 05/13/2008 - (DGNews)
    Mother's High Normal Glucose Levels May Increase Risk of Infant Birth Problems - (DGNews)
    Metabolic Syndrome Increases Diabetes Risk in Patients With Adult-Onset Growth hormone Deficiency: Presented at ECE - (DGDispatch)
    Metformin versus insulin for the treatment of gestational diabetes - (N Engl J Med)
    Vascular Calcifications on Mammography Foretell Coronary Disease and Diabetes Risks: Presented as ASBS - (DGDispatch)

    News archive

     Recent webcasts/CME - Diabetes
      New Insulins in the Management of Diabetes
      Diabetes: Management of Type 2 Diabetes
      Use of Direct Thrombin Inhibitors for Treating Non-St-Segment Elevation Acute Coronary Syndromes in Special Patient Groups: Women, Diabetics, the Elderly, and Chronic Renal Insufficiency
      Islet Cell Transplant in DM
      Winning CV and Metabolic Parameters

      Webcasts/CME archive

       Recent cases - Diabetes
        Treatment with Pioglitazone Induced Significant, Reversible Mitral Regurgitation
        An Elderly Patient with Sarcoidosis Manifesting Panhypopituitarism with Central Diabetes Insipidus
        Melioidosis Presenting as Genitourinary Infection in Two Men with Diabetes
        South Beach Diet Associated Ketoacidosis: A Case Report
        Consideration of Polypharmacology in Regards to Effective Weight Reduction: A Patient on Diabetes Medication

        Cases archive
          




        my personal edition > diabetes > news
        divider

          E-Mail this DGDispatch to a colleague

        DGDispatch


        Avandia (Rosiglitazone) Lowers Markers for Cardiovascular Inflammation in Diabetic Patients: Presented at ADA

        By Bruce Sylvester
        Special to DG News

        SAN FRANCISCO, CA -- June 17, 2002 -- Avandiaź (rosiglitazone) appears to lower markers of cardiovascular inflammation -- a precursor of atherosclerosis and heart disease -- in diabetic patients.

        Blood-borne oxygen free radicals can injure vessel linings, initiating vascular inflammation that induces atherosclerosis and heart disease. The investigators found that rosiglitazone, a widely used insulin sensitizer, has a profound inhibitory effect on oxygen free radicals. They reported their findings here Saturday at the annual meeting of the American Diabetes Association (ADA).

        Atherosclerosis is a leading cause of heart disease, which diabetics suffer at twice the rate of non-diabetics.

        "Lowering inflammation is fundamental in the prevention of atherosclerosis and cardiovascular disease," said Paresh Dandona, MD, professor of endocrinology at the University of Buffalo School of Medicine and Biomedical Sciences, in Buffalo, New York, United States. "Other research indicates that rosiglitazone lowers markers of cardiovascular disease in patients at risk for diabetes. We took the research one step further, studying diabetics. We found a significant anti-inflammatory effect emerging from blood data acquired from our diabetic subjects."

        The researchers enrolled 11 obese patients with Type 2 diabetes and initiated a six-week daily dosing regimen of rosiglitazone 4 mg/day. They took fasting blood samples at 0, 1, 2, 4, 6 and 12 weeks and analyzed the blood for concentrations of three inflammatory markers and oxygen free radicals.

        The investigators measured nuclear factor k (NF-kB) binding activity in mononuclear cells (MNC), reactive oxygen species (ROS) generation by MNC, plasma monocyte chemoattractant protein-1 (MCP-1) and C-reactive protein (CRP), as well as brachial artery reactivity using post-ischemic flow mediated dilation (FMD).

        At week 6, blood glucose concentration decreased from 157±16 to 127±9 mg/dL and insulin concentration fell from 32.6±4.6 to 16.1±2.2 mU/mL (p<0.05). NF-kB binding activity in MNC nuclear extract also declined significantly (p<0.02); inhibition was significant by week 1 (77±13 percent of the basal level) and continued up to week 6 (66±10.6 percent of basal).

        ROS generation by MNC fell significantly to 94±6 percent by week 1 and 66±10 percent at week 6 (p<0.05). Rosiglitazone treatment also reduced plasma MCP-1 (75 percent of the basal level; p<0.05) and CRP (70 percent of basal; p<0.05).

        FMD at baseline was 3.4±1.2 percent, which increased to 8.6±1.9 percent (p<0.05) at week 6. Nitroglycerin-induced endothelium independent vasodilatation increased from 11.8±1.4 percent at baseline to 16.7±2.3 percent at week 6 (p<0.05).

        "Rosiglitazone exerts a profound ROS suppressive and anti-inflammatory effect as reflected at the cellular and molecular level, and in plasma. Rosiglitazone also improves vascular reactivity," the authors concluded. "These observations may have implications for atherogenesis in the long-term in patients treated with rosiglitazone. At 12 weeks, after the subjects had been off treatment for six weeks, inflammatory markers had returned to pre-trial levels."

        Rosiglitazone sensitizes cells to insulin, causing them to absorb more of the reduced amount of bodily insulin that diabetics produce.

        The study was supported by GlaxoSmithKline, the manufacturer of Avandia.



        E-Mail this DGDispatch to a colleague   To print, use this version






        All contents Copyright (c) 1995-2008 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send